BVF Partners L.P.: A San Francisco-based financial firm specializing in long-term biotech investments.
Location
San Francisco, CA, US
Biotechnology Value Fund (BVF) is a San Francisco-based private investment partnership that focuses on fundamentally-driven public biotechnology investments. Since its inception in 1993, BVF has concentrated on building long-term investments in small-cap biotechnology companies. The firm typically engages in Series A to Series E rounds, as well as post-IPO equity and debt investments, with a commitment to rigorous diligence and ongoing monitoring of its portfolio.
BVF's notable portfolio companies include 4D Molecular Therapeutics, Aadi Bioscience, Alpine Immune Sciences, and Black Diamond Therapeutics. The firm is known for its collaborative approach, working closely with portfolio companies to support their growth and success. Key partners and decision-makers at BVF bring extensive experience and industry knowledge, contributing to the firm's reputation for strategic and impactful investments in the biotechnology sector.
BVF Partners - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages